PP
AMAG

PDT Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

PDT Partners’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-96,842
Closed -$967K – 502
2019
Q2 		$967K Buy
96,842
+24,842
+35% +$268K 0.06% 257
2019
Q1 		$927K Hold
72,000
– – 0.05% 268
2018
Q4 		$1.09M Buy
+72,000
New +$1.37M 0.06% 268
2017
Q4 		– Sell
-293,400
Closed -$5.41M – 582
2017
Q3 		$5.41M Buy
+293,400
New +$5.47M 0.18% 172
2015
Q4 		– Sell
-125,550
Closed -$4.99M – 1095
2015
Q3 		$4.99M Buy
+125,550
New +$7.79M 0.11% 228
2014
Q3 		– Sell
-12,832
Closed -$266K – 1692
2014
Q2 		$266K Sell
12,832
-38,618
-75% -$714K 0.01% 1229
2014
Q1 		$996K Buy
+51,450
New +$1.09M 0.02% 678

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PDT Partners's AMAG Position: Q3 2019 in Review

PDT Partners sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 96,842 shares — an estimated $967K sold.

PDT Partners first reported a position in AMAG in Q1 2014 and held it in 7 quarters. The position peaked at $5.41M in Q3 2017. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

  • PDT Partners reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • PDT Partners sold 96,842 AMAG Pharmaceuticals shares in Q3 2019, an estimated $967K.
  • PDT Partners first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 7 quarters.
  • PDT Partners's AMAG Pharmaceuticals position peaked at $5.41M in Q3 2017.
  • 156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on PDT Partners's 13F filing for Q3 2019, filed 14 Nov 2019.